Information Provided By:
Fly News Breaks for May 31, 2017
WBA, RAD
May 31, 2017 | 07:59 EDT
Cowen analyst Charles Ryhee said the FTC decision on the merger between Walgreens (WBA)and Rite Aid (RAD) is too difficult to call, but he believes although Rite Aid will struggle on its own its value to Walgreens is significant. He also believes the value is well above the deal price range and so expects Walgreens will litigate the decision in an attempt to win an approval. Ryhee reiterated his Outperform rating but lowered his price target to $4.70 from $6.75 on Rite Aid shares.
News For RAD;WBA From the Last 2 Days
RAD, WBA
Mar 28, 2024 | 16:23 EDT
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
WBA
Mar 28, 2024 | 12:00 EDT
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
WBA
Mar 28, 2024 | 08:59 EDT
Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here
WBA
Mar 28, 2024 | 07:12 EDT
Consensus $3.24. The company said the change reflects challenging retail environment in the U.S., early wind-down of sale-leaseback program, and lower earnings due to Cencora share sales, offset by execution in pharmacy services and a lower adjusted effective tax rate. The company is also maintaining its U.S. Healthcare adjusted EBITDA view to be breakeven at the midpoint of the guidance range of loss of $50M to gain of $50M.
WBA
Mar 28, 2024 | 07:05 EDT
Reports Q2 revenue $37.05B, consensus $35.86B. The company said, "We're encouraged by our first quarter of U.S. Healthcare positive adjusted EBITDA and continued topline growth alongside another quarter of strong execution in pharmacy, as we look to re-energize and evolve its impact both at Walgreens and at large. As we continue to operate in a challenging retail environment, we are taking actions to focus on customer engagement and value.We remain confident in our goal of achieving $1 billion in cost savings this year. We are continuing to strategically review our portfolio over the next three months in an effort to ensure it drives growth and delivers value. Our team members, led by WBA's new executive committee with a track record of operational excellence, are powering our progress as we map growth opportunities, aim to create long-term value across our businesses and execute the hard work to simplify and strengthen WBA."
WBA
Mar 27, 2024 | 13:20 EDT
Notable companies reporting before tomorrow's open, with earnings consensus, include Walgreens Boots Alliance (WBA), consensus 82c.